SANUWAVE Health, Inc.  

(Public, OTCMKTS:SNWV)   Watch this stock  
Find more results for SNWV)
0.0655
-0.0045 (-6.43%)
Feb 5 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.06 - 0.07
52 week 0.04 - 0.28
Open 0.06
Vol / Avg. 25,600.00/135,422.00
Mkt cap 4.13M
P/E     -
Div/yield     -
EPS -0.06
Shares 63.06M
Beta 0.51
Inst. own 17%
May 4, 2016
Q1 2016 SANUWAVE Health Inc Earnings Release (Estimated) Add to calendar
Dec 15, 2015
Q4 2015 SANUWAVE Health Inc Earnings Release
Nov 13, 2015
Q3 2015 SANUWAVE Health Inc Earnings Call
Nov 12, 2015
SANUWAVE Health Inc at SeeThruEquity LLC Microcap Investor Forum
Nov 12, 2015
Q3 2015 SANUWAVE Health Inc Earnings Release
  

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -715.02% -705.01%
Operating margin -919.55% -703.76%
EBITD margin - -665.88%
Return on average assets -203.09% -191.04%
Return on average equity - -
Employees 8 -
CDP Score - -

Address

11475 Great Oaks Way Ste 150
ALPHARETTA, GA 30022-2482
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links

Description

SANUWAVE Health, Inc. (SANUWAVE) is a shockwave technology company using a system of noninvasive, acoustic shockwaves for regenerative medicine and other applications. The Company's initial focus is regenerative medicine, utilizing noninvasive, acoustic shockwaves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers, which is in a supplemental Phase III clinical study. The Company's portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Lisa E. Sundstrom Chief Financial Officer
Age: 45
John F. Nemelka Director
Age: 49
Alan L. Rubino Independent Director
Age: 60